Privately-held UK biotech Curve Therapeutics today announced the further strengthening of its leadership team with the appointments of Andre Hoekema as chairman of the board and Cora Griffin as head of business development. 2 October 2024
NK:IO, a London startup developing a cell therapy for treating solid tumors, has announced the appointment of a permant chief executive and the finalization of a seed funding round. 2 October 2024
Halda Therapeutics, a US biotech company advancing cancer treatments, announced the appointment of Christian Schade as president and chief executive. 1 October 2024
AstronauTx, a biotech developing novel treatments for Alzheimer's disease and other neurodegenerative disorders, has announced the appointment of Jane Rhodes as chief executive officer. 1 October 2024
USA-based engineered regulatory T cells (Tregs) company GentiBio today announced the appointment of Dr Mark Bach as chief medical officer. 30 September 2024
Recently-created by US biotech incubator Flagship Pioneering, Abiologics has announced the appointment of Maria-Chiara Magnone as its chief scientific officer. 26 September 2024
German privately-held biotech ARTCLINE Bio-Therapies today announced the appointment of Dirk Hessel as additional managing director of the company. 23 September 2024
Stalicla, a privately-held Swiss biotech, today announced that Dr Paulo Fontoura will be joining its drug development team as chief scientific and clinical development advisor. 19 September 2024
US contract development and manufacturing organization (CDMO) BioCentriq has appointed Syed Husain as its new chief executive (CEO), and as a member of the board of directors. 19 September 2024
Californian biopharma 89bio, a company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, has announced an important appointment. 17 September 2024
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Ohio, USA-based Trailhead Biosystems has appointed Josh Snow as its new chief commercial officer, as the company moves to expand its presence in the commercial market with its iPSC-derived human cell products. 16 September 2024
US neurological diseases specialist Ovid Therapeutics has announced the promotion of Meg Alexander to president and chief operating officer (COO). 12 September 2024
French cancer focused biotech Transgene has appointed two seasoned leaders in oncology who will be instrumental in advancing the company’s innovative immunotherapy programs 10 September 2024
Italy-based biotech AAVantgarde Bio has appointed Jayashree Sahni as its new chief medical officer, replacing Naveed Shams, who has held the role since 2022. 10 September 2024
US biotech major Gilead Sciencestoday announced that Johanna Mercier will join the company as chief commercial officer, and will become a member of the company’s senior leadership team. 29 May 2019
Cambridge, Massachusetts-based genome editing company Intellia Therapeutics has named Laura Sepp-Lorenzino as its new executive vice president and chief scientific officer. 28 May 2019
Akrevia Therapeutics, a privately-held biopharma that was launched in September 2018 by Atlas and F-Prime, has now named its first chief executive. 23 May 2019
Oncology heavyweight Robin Taylor has made the switch from VP level at big pharma to chief commercial officer at an emerging, multi-product biotech company. 23 May 2019
US biotech firm bluebird bio has appointed Joanne Smith-Farrell to chief business officer. In this role, she will lead corporate development and strategy, and she will also continue to serve as our oncology franchise leader. 2 May 2019
Swedish Orphan Biovitrum, the Nordic biotech company known as Sobi, has appointed Amy Pott as the new head of Sobi North America. She takes over effective today, replacing Rami Levin who is leaving Sobi. 30 April 2019
British biotech Kymab has appointed Simon Sturge as its new chief executive, effective 1 May 2019. Mr Sturge will replace David Chiswell, who has been in the role since 2015. 10 April 2019
French privately-held biotech firm Enterome Bioscience has named Jan Fagerberg its new chief medical officer and Catherine Mathis its chief development officer. 3 April 2019
Daniel Welch, the man who previously headed up several biotechs that were sold to pharma majors over the past several years, has joined privately-held US biopharma company InCarda Therapeutics as executive chairman. 3 April 2019
California, USA-based biopharma company Tenaya Therapeutics, which is focused on developing potentially curative treatments for heart disease, today announced that it has strengthened its leadership team. 14 March 2019
Dutch biopharma Kiadis Pharma today announced senior management appointments to further strengthen the company as it transitions into commercial stage. 6 March 2019
UK-based biotech firm Emergex Vaccines today announces the appointment of Athanasios Papadopoulos as chief medical officer, effective March 1, 2019. 27 February 2019
The UK’s BioIndustry Association (BIA) chairwoman Dr Jane Osbourn has announced this week that she is to leave AstraZeneca after 25 years with Cambridge Antibody Technology and MedImmune, where she is vice president R&D and site leader, the trade group announced yesterday. 19 February 2019
Dutch biopharma Kiadis Pharma has announced the appointment of Robert Friesen as chief scientific officer (CSO) effective February 1, 2019. 5 February 2019